2 Numbers That Should Make Novavax Shareholders Smile
Novavax executives are talking about making big bucks this year.
Source: fool.com
Stay updated with breaking news from Stan Erck. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novavax executives are talking about making big bucks this year.
Novavax executives are talking about making big bucks this year.
The protein-based shot, already authorized in some parts of the world, has faced long delays, and it is not clear what role it will play in the United States.
NVAX earnings call for the period ending September 30, 2021.
Pfizer's new data on the drug, Paxlovid, came from an interim analysis of its Phase II/III trial among more than 770 high-risk adults with Covid-19 who were treated within three days of the onset of symptoms or given a placebo.